Bank Julius Baer & Co
SAGE icon

Bank Julius Baer & Co’s Sage Therapeutics SAGE Stock Holding History

Bank Julius Baer & Co’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,098
Closed -$268K – 886
2020
Q4 		$268K Sell
3,098
-30,521
-91% -$2.25M ﹤0.01% 528
2020
Q3 		$2.06M Buy
33,619
+7,146
+27% +$362K 0.02% 224
2020
Q2 		$1.1M Buy
+26,473
New +$961K 0.01% 259

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank Julius Baer & Co's SAGE Position: Q1 2021 in Review

Bank Julius Baer & Co sold out of Sage Therapeutics (SAGE) in Q1 2021, closing a stake of 3,098 shares — an estimated $268K sold.

Bank Julius Baer & Co first reported a position in SAGE in Q2 2020 and held it in 3 quarters. The position peaked at $2.06M in Q3 2020. 263 funds tracked by Wall St. Rank hold SAGE as of Q1 2021.

  • Bank Julius Baer & Co reported no remaining Sage Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 3,098 Sage Therapeutics shares in Q1 2021, an estimated $268K.
  • Bank Julius Baer & Co first reported a position in Sage Therapeutics in Q2 2020 and held it in 3 quarters.
  • Bank Julius Baer & Co's Sage Therapeutics position peaked at $2.06M in Q3 2020.
  • 263 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2021.

Based on Bank Julius Baer & Co's 13F filing for Q1 2021, filed 10 May 2021.